CLASS II Device recall · Reported 31 Oct 2018 · FDA Enforcement Report

MyLab Gamma recalled by Esaote S.p.a

Esaote is recalling MyLab Gamma, distributed nationwide in the US. The recall was initiated on 11 Jun 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesn/a
Quantity recalled10

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0205-2019
FDA event ID
81285
Recalling firm
Esaote, Sesto Fiorentino, N/A
Classification
Class II
Status
Terminated
Recall initiated
11 Jun 2018
FDA classified
23 Oct 2018
Reported
31 Oct 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

11 Jun 2018Recall initiated by company
23 Oct 2018Classified by FDA+134 days
31 Oct 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The probe power monitoring settings have been found to be not appropriate under specific operating conditions when connected to the devices listed below. This issue may result in overheating of the probe head. The probe power monitoring settings may not be effective in specific operating conditions so that the surface of the probe head may overheat in around one minute of continuous operations. The patient may experience discomfort, reddening of epidermis and/or mild pain. To date, no patient injury has been reported with regards to this issue.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

MyLab Gamma, Model 7410

Where it was distributed

Worldwide distribution - US Nationwide in the states of AK, AZ, CA, IN, MO, NM, PA, SC, and TX. and countries Argentina and Australia Austria Bangladesh Belgium Brazil Bulgaria China Costa Rica Denmark Egypt Finland France Germany Greece Hong Kong Hungary Iceland India Iran Italy Japan Kuwait Mexico Netherlands Norway Paraguay Poland Portugal Russian Fed. Saudi Arabia Singapore Slovenia South Africa South Korea Spain Switzerland Taiwan Thailand Tunisia Turkey United Kingdom Utd.Arab Emir.

Nationwide AlaskaArizonaCaliforniaIndianaMissouriNew MexicoPennsylvaniaSouth CarolinaTexas

Questions about this recall

Why was it recalled?

The probe power monitoring settings have been found to be not appropriate under specific operating conditions when connected to the devices listed below. This issue may result in overheating of the probe head. The probe power monitoring settings may not be effective in specific operating conditions so that the surface of the probe head may overheat in around one minute of continuous operations. The patient may experience discomfort, reddening of epidermis and/or mild pain. To date, no patient injury has been reported with regards to this issue.

Which lots are affected?

n/a

Where was it sold?

Worldwide distribution - US Nationwide in the states of AK, AZ, CA, IN, MO, NM, PA, SC, and TX. and countries Argentina and Australia Austria Bangladesh Belgium Brazil Bulgaria China Costa Rica Denmark Egypt Finland France Germany Greece Hong Kong Hungary Iceland India Iran Italy Japan Kuwait Mexico Netherlands Norway Paraguay Poland Portugal Russian Fed. Saudi Arabia Singapore Slovenia South Africa South Korea Spain Switzerland Taiwan Thailand Tunisia Turkey United Kingdom Utd.Arab Emir.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 81285
ReportedClassRecallCompanyReasonWhere
CLASS IIMyLab Alpha recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide
CLASS IIMyLab Seven recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide

More recalls from Esaote

All 9
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIEndocavity ultrasonic probe recalled by Esaote S.p.aEsaotePackaging DefectsNationwide
DeviceCLASS IIAC/DC Power Supply recalled by Esaote S.p.aEsaoteOtherNationwide
DeviceCLASS IIAC/DC Power Supply recalled by Esaote S.p.aEsaoteOtherNationwide
DeviceCLASS IIMyLab Seven recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide
DeviceCLASS IIMyLab Alpha recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide

Other Other Medical Devices recalls

All 13,929